Concepedia

Antony Loebel

AL

Statistics

Publications

119

Citations

7.8K

H-Index

48

Active since

1992

Affiliations

Vion Pharmaceuticals (United States)(Current)

Sunovion (United States)

Pfizer (United States)

Sunovion (United Kingdom)

Zucker Hillside Hospital

Antony Loebel is an author at Vion Pharmaceuticals (United States) specializing in psychopharmacology, psychiatry, and pharmacotherapy.

ORCID

Publications per year

1992–2023

119

Publications

119

Duration of psychosis and outcome in first-episode schizophrenia

Antony Loebel, Jeffrey A. Lieberman, José Alvir et al. · American Journal of Psychiatry · 1992 · 881 citations

, , +15

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Antony Loebel, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2013 · 340 citations

, , +17

Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study

Trisha Suppes, Robert Silva, Josephine Cucchiaro et al. · American Journal of Psychiatry · 2015 · 317 citations · Full text

, , +16

Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Antony Loebel, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2013 · 292 citations

, , +17

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

Kenneth S. Koblan, Justine Kent, Seth C. Hopkins et al. · New England Journal of Medicine · 2020 · 288 citations

, , +17

1–5 of 119